CoChat

Allergen Immunotherapy for Birch-Apple Syndrome: What Do We Know?

Incorvaia, Cristoforo, Ridolo, Erminia, Mauro, Marina, Russello, Marina, Pastorello, Elide · 2017 · Immunotherapy
Cited by 16

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Apple allergy is common in patients allergic to birch pollen, and this is defined as 'birch-apple syndrome'. Allergens responsible for cross-reactivity belong to the pathogenesis-related-10 family, and high homology in the amino acid sequences of the major allergens Bet v 1 from birch and Mal d 1 from apple has been demonstrated. Here we review the literature on the treatment of birch-apple syndrome by allergen immunotherapy. The only allergen immunotherapy method available thus far is based on the administration of birch-pollen extracts, through the subcutaneous or sublingual route, to induce tolerance to Bet v1 and to the homologous allergen Mal d 1. However, the studies performed thus far show modest efficacy, and thus other methods of immunotherapy should be investigated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2217/imt-2017-0040

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 16

Metadata

Authors
Incorvaia, C., Ridolo, E., Mauro, M., Russello, M., & Pastorello, E.
Venue
Immunotherapy
Published
2017-11
Volume
9
Issue
15
Pages
1271-1278
ISSN
  • 1750-743X (ISSN-L)
  • 1750-7448
OpenAlex
W2770226497
Cited by
16
References
3
FWCI
0.90
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Allergen Immunotherapy for Birch-Apple Syndrome: What Do We Know? https://app.cochat.ai/papers/10.2217/imt-2017-0040
The paper
Incorvaia, C., Ridolo, E., Mauro, M., Russello, M., & Pastorello, E. (2017). Allergen Immunotherapy for Birch-Apple Syndrome: What Do We Know? Immunotherapy. https://doi.org/10.2217/imt-2017-0040

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.